Cross-reactive antibodies prevent the lethal effects of Staphylococcus aureus superantigens

Journal of Infectious Diseases

Volumn 180, Issue 4, 1999, Pages 1365-1369

  Bavari, Sina ^a   Ulrich, Robert G ^a   LeClaire, Ross D ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CROSS REACTING ANTIBODY; EPITOPE; EXOTOXIN; STAPHYLOCOCCUS ENTEROTOXIN; SUPERANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; VACCINATION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY FORMATION; BACTERIAL TOXINS; CROSS REACTIONS; ENTEROTOXINS; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; SPECIFIC PATHOGEN-FREE ORGANISMS; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS;

EID: 0033389240     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314977     Document Type: Article

References (11)

1. Fraser JD. High-affinity binding of staphylococcal enterotoxins A and B to IILA-DR. Nature 1989; 339:221-3.
2. Ulrich RG, Bavari S, Olson MA. Bacterial superantigens in human disease: structure, function, and diversity. Trends Microbiol 1995; 3:463-8.
3. Hudson KR, Tiedemann RE, Urban RG, Lowe SC, Strominger JL, Fraser JD. Staphylococcal enterotoxin A has two cooperative binding sites on major histocompatibility complex class H. J Exp Med 1995; 182:711-20.
4. Roussel A, Anderson BF, Baker HM, Fraser JD, Baker EN. Crystal structure of the streptococcal superantigen SPE-C: dimerization and zinc binding suggest a novel mode of interaction with MHC class II molecules. Nat Struct Biol 1997; 4:635-43.
5. Bavari S, Dyas B, Ulrich RG. Superantigen vaccines: a comparative study of genetically attenuated receptor binding mutants of staphylococcal enterotoxin A. J Infect Dis 1996; 174:338-45.
6. Bavari S, Olson MA, Dayas B, Ulrich RG. Engineered bacterial superantigen vaccines. In: Vaccines. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1996; 135-41.
7. Herman A, Kappler, JW, Marrack P, Pullen AM. Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu Rev Immunol 1991; 9:745-72.
8. Heeg K, Wagner H. Induction of responsiveness in superantigen-induced anergic T cells: role of ligand density and costimulatory signals. J Immunol 1995; 155:83-92.
9. Heeg K, Gaus H, Griese D, Bendigs S, Miethke T, Wagner H. Superantigen-reactive T cells that display an anergic phenotype in vitro appear functional in vivo. Int Immunol 1995; 7:105-14.
10. Gaus H, Meithke T, Wagner H, Heeg K. Superantigen-induced anergy of Vβ 8′ CD4′ T cells induces functional but nonproliferative T cells in vivo. Immunology 1994; 83:333-40.
11. Vella AT, McCormack JE, Linsley PS, Kappler JW, Marrack P. Lipopolysaccharide interferes with the induction of peripheral T cell death. Immunity 1995; 2:261-70.